Patents by Inventor Shining Yao

Shining Yao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11390591
    Abstract: The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: July 19, 2022
    Assignee: Aluda Pharmaceuticals, Inc.
    Inventors: Qizheng Yao, Jianping Wu, Ruihuan Chen, Lei Zhang, Shining Yao, Lian Mo, Qingqing Zhang
  • Patent number: 10611736
    Abstract: The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: April 7, 2020
    Assignee: Aluda Pharmaceuticals, Inc.
    Inventors: Qizheng Yao, Jianping Wu, Ruihuan Chen, Lei Zhang, Shining Yao, Lian Mo, Qingqing Zhang
  • Patent number: 9868734
    Abstract: The present invention relates to an oxo indirubin or isoindigo derivative, an oxo aza indirubin or isoindigo derivative, and their optical isomers, racemes, cis/trans isomers and pharmaceutically acceptable salts, which can be used for preparing a drug for treating or preventing diseases such as glucose metabolic disorder, inflammatory or autoimmune disease, neurodegenerative disease, a mental illness, tissue proliferation disease or tumors.
    Type: Grant
    Filed: May 26, 2014
    Date of Patent: January 16, 2018
    Assignee: Luoda Biosciences, Inc.
    Inventors: Qizheng Yao, Jiajia Liu, Zhaohui Wang, Kui Wu, Yongbin Wang, Shining Yao, Ruihuan Chen, Beibei Yang
  • Publication number: 20160185771
    Abstract: The present invention relates to an oxo indirubin or isoindigo derivative, an oxo aza indirubin or isoindigo derivative, and their optical isomers, racemes, cis/trans isomers and pharmaceutically acceptable salts, which can be used for preparing a drug for treating or preventing diseases such as glucose metabolic disorder, inflammatory or autoimmune disease, neurodegenerative disease, a mental illness, tissue proliferation disease or tumors.
    Type: Application
    Filed: May 26, 2014
    Publication date: June 30, 2016
    Inventors: Qizheng Yao, Jiajia Liu, Zhaohui Wang, Kui Wu, Yongbin Wang, Shining Yao, Ruihuan Chen, Beibei Yang